All articles tagged with #biopsy
NHS England will pilot AI-assisted analysis of lung scans paired with robot-guided biopsies at Guy’s and St Thomas’ to speed detection of small nodules, aiming to screen all smokers and ex-smokers by 2030 and diagnose more cancers earlier, potentially speeding treatment and reducing invasive procedures.
Nicole 'Snooki' Polizzi revealed cancerous cells were found on her cervix after a colposcopy and biopsy, with a cone biopsy planned under anesthesia; she urges others not to delay cervical screenings and faces the possibility of a hysterectomy if further testing is needed, while receiving support from her Jersey Shore cast.
Drew Barrymore shared her personal experience of a breast cancer scare involving a bad mammogram and emergency biopsy on her show, inspired by Tig Notaro's story, highlighting the importance of awareness and support during such health crises.
NHS hospitals will test a new AI tool called ArteraAI Prostate Biopsy Assay to improve diagnosis and treatment decisions for prostate cancer, using data from over 4,000 men in a three-year study funded by Prostate Cancer UK, aiming to enhance personalized care and reduce over- and under-treatment.
Stanford Medicine researchers have developed an AI tool called SEQUOIA that can predict gene activity in tumor cells using standard biopsy images, potentially replacing costly and time-consuming genetic sequencing. This tool, which analyzes over 15,000 genes, could expedite clinical decision-making and reduce healthcare costs. SEQUOIA has shown high accuracy in predicting gene expression and patient outcomes, particularly in breast cancer, but requires further testing and FDA approval before clinical use.
Dr. Roach addresses concerns about cellphone radiation, stating there is no definitive evidence linking it to brain cancer. He also discusses a case involving a retroperitoneal mass near the kidney, recommending a biopsy and consultation with multiple specialists to determine the appropriate treatment plan.
Melanoma diagnoses have increased significantly in recent years, but experts believe that many of these cases are due to overdiagnosis rather than a true increase in the disease. A study suggests that a majority of people in the United States are receiving unnecessary melanoma diagnoses, leading to unnecessary treatments, financial costs, and emotional distress. Overdiagnosis is particularly common for thin moles on the outermost layer of the skin. There is a lack of scientific evidence supporting regular full-body skin checks, and experts recommend that individuals seek medical evaluation for any new or changing skin spots rather than undergoing routine screenings.
Aya McMillan, diagnosed with breast cancer after a series of personal losses, felt a comforting touch during a difficult double biopsy procedure, which helped her through the ordeal. The act of kindness from an unknown person provided much-needed support during a lonely and challenging time, leaving a lasting impression on her.
Flat polyps, which are harder to remove, may require surgery if they show severe dysplasia close to becoming cancer. However, if the pathology is less concerning, a follow-up colonoscopy in six to 12 months may be reasonable. As for the pneumonia vaccine, a reaction to the previous vaccine 15 years ago should not deter a healthy individual from getting the recommended pneumonia vaccine, which is the PVC20 (Prevnar). The benefit outweighs the risk, especially considering the individual's family history with pneumonia.
Artificial intelligence (AI) has shown to be nearly twice as accurate as biopsies in assessing the aggressiveness of rare types of cancer, according to a study by researchers from the Royal Marsden NHS Foundation Trust and the Institute for Cancer Research. The AI algorithm, trained on CT scans of patients with retroperitoneal sarcoma, accurately assessed tumor aggressiveness 82% of the time, compared to 44% for biopsies. The technology also predicted the type of sarcoma in 84% of cases, compared to 65% for radiologists. The researchers believe this approach could improve diagnosis, treatment planning, and outcomes for patients with retroperitoneal sarcoma and potentially other types of cancer.
Artificial intelligence (AI) has been found to be nearly twice as accurate as a biopsy in assessing the aggressiveness of certain cancers, according to a study by the Royal Marsden NHS foundation trust and the Institute of Cancer Research. The AI algorithm was particularly effective in grading the aggressiveness of sarcomas, a rare form of cancer that develops in connective tissues. By providing clinicians with a more accurate way of grading tumors, AI could improve outcomes for patients by identifying high-risk individuals more quickly and sparing low-risk patients unnecessary treatments. The algorithm could potentially be applied to other types of cancer in the future.
Biopsy results have revealed that Kipenzi, a Masai giraffe at Seneca Park Zoo, has squamous cell carcinoma, a type of cancer that is invasive through the jawbone. The tumor cannot be surgically removed without compromising Kipenzi's ability to eat, and the prognosis is poor. The zoo will closely monitor Kipenzi's behavior and tumor growth, and if she experiences severe pain and medications are ineffective, euthanasia may be considered to prevent her from suffering.
Kipenzi, a 6-year-old Masai giraffe at Seneca Park Zoo, has a life-threatening growth under her jaw that is impacting her ability to eat. Veterinarians will perform a biopsy and radiograph to determine the nature of the growth, which they suspect could be a tumor. Anesthesia poses risks for giraffes due to their body structure, but the team will carefully monitor Kipenzi's vital signs during the procedure. If the growth is determined to be malignant, there may be limited treatment options available.
Medicare's new guidance on billing for post-transplant care is causing delays and confusion, putting the health of transplant patients at risk. Patients are unable to receive necessary tests and monitoring, leaving them vulnerable to infections and organ rejection. This is particularly concerning for patients who have already had multiple transplants and may not be eligible for another one if their current organ fails.
Researchers from Stanford University have developed a method of genetically adjusting PSA levels to screen out the "noise" and better identify those truly at risk of prostate cancer. In the study of nearly 100,000 men published in the journal Nature Medicine, the team found 128 locations across the genome associated with PSA. They developed a risk score that indicates whether each man's combination of genetic variants in those locations is likely to give him a naturally high, low or normal PSA. The genetically adjusted PSA better predicted aggressive prostate cancers and would have prevented up to 31% of unnecessary biopsies.